Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00
Provider: Sadif Analytics Prime
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux SA Announces Share Repurchase Program


Wednesday, 29 May 2013 11:37am EDT 

BioMerieux SA announced that its Board of Directors has authorized the Company to repurchase percentage of maximum authorized capital redemption by the Assembly of 10% of the share capital of the Company, which represented on May 29, 2013, 3,945,374 shares. The percentage of maximum redemption of shares acquired by the Company for their conservation and their subsequent delivery in payment or exchange as part of a merger, demerger or contribution is 5% with a maximum unit purchase price not exceeding EUR 100 per share (excluding acquisition costs). Overall, maximum amount of the program with total amount of funds for the implementation of this program to purchase shares may not exceed EUR 394,537,400. 

Company Quote

85.87
0.57 +0.67%
6:37am EST